Company Filing History:
Years Active: 2016
Title: Mathew Louis Coleman: Innovator in Biomedical Research
Introduction
Mathew Louis Coleman is an accomplished inventor based in Oxford, GB, known for his significant contributions to the field of biomedical research. With a focus on enzymatic activity, he has made strides in understanding histidinyl hydroxylase and its related functions within human proteins.
Latest Patents
Mathew holds one patent titled "Assay for histidinyl hydroxylase activity." This innovation pertains to assays designed to monitor the activity of Mina53 and NO66, crucial components in understanding various biological processes. The patent further outlines assays to evaluate the histidinyl hydroxylase activity of these proteins on their respective substrates, specifically targeting the human ribosomal proteins Rpl27a and Rpl8. This invention allows for the introduction of S-3-hydroxyhistidinyl residues into peptides and proteins, marking a significant advancement in the field.
Career Highlights
Mathew is affiliated with Isis Innovation Limited, a company dedicated to offering innovative solutions and fostering technological advancements. His work at this establishment highlights his ongoing commitment to collaboration and advancement in scientific research.
Collaborations
Throughout his career, Mathew has collaborated with notable colleagues, including Christopher Joseph Schofield and Wei Ge. These partnerships reflect a shared vision for innovation in the biomedical sector and underscore the importance of teamwork in research and development.
Conclusion
Mathew Louis Coleman exemplifies the spirit of innovation in the realm of biomedical research. His singular patent represents the potential for breakthroughs that could change the course of scientific understanding and treatment methodologies. As he continues to work alongside talented individuals in the industry, the impact of his contributions is sure to grow.